Search clinical trials for: Gadolinium Contrast

Total 1984 results

ECOG-ACRIN Cancer Research Group

Not yet recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype
Massachusetts General Hospital

Recruiting

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Liver Cirrhosis | Portal Hypertension | Hepatic Cell Carcinoma

United States
Bayer

Not yet recruiting

An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

Contrast Enhancement in Magnetic Resonance Imaging
Centre Hospitalier Régional Metz-Thionville
University of Lorraine

Recruiting

Kinetics of Urinary Excretion of Gadolinium Contrast Agents Used in MRI Examinations (GADODURABLE)

Magnetic Resonance Imaging

France
OHSU Knight Cancer Institute
Oregon Health and Science University

Recruiting

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Glioma

United States
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)

Contrast Enhancement in Magnetic Resonance Imaging | Non-central Nervous System Pathology

United States, Sweden, Japan, Czechia, China, Hungary, Poland, Italy, United Kingdom, Turkey, Korea, Republic of, Germany, Taiwan, France, Argentina, Bulgaria, Canada
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)

Contrast Enhancement in Magnetic Resonance Imaging | Central Nervous System Pathology

France, Turkey, Czechia, China, Japan, United States, United Kingdom, Italy, Korea, Republic of, Germany, Bulgaria, Hungary, Argentina, Canada, Sweden
Beijing Tiantan Hospital

Recruiting

Multi-center Study of Artificial Intelligence Model for Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET) (MAGNET)

Brain Diseases

China
NYU Langone Health

Recruiting

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection

United States
Indiana University
Children's Hospital of Philadelphia

Recruiting

Registering Genomics and Imaging of Tumors (ReGIT) (ReGIT)

Glioma

United States
University Hospital, Grenoble

Not yet recruiting

Acceleration of the Kinetics of Diffusion of Gadolinium in the Perilymphatic Structures of the Inner Ear. (FAST-HYDROPS)

Inner Ear ; Meniere's Disease; Imaging
The Central Hospital of Lishui City
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Nephrogenic Fibrosing Dermopathy

China
University Health Network, Toronto

Not yet recruiting

Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging

Stroke | Neurovascular Disorder | Stenosis, Carotid

Canada
Stanford University
NovoCure Ltd.

Recruiting

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma | Newly Diagnosed Glioblastoma

United States
Guerbet
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY)

Cognitive Function | Motor Function | Contrast Media

United States, Korea, Republic of, Italy, Brazil, Canada, Russian Federation
University of California, San Diego
Icahn School of Medicine at Mount Sinai; Bayer Healthcare Pharmaceuticals,...

Recruiting

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Liver Cancer | Liver Carcinoma | Liver Cirrhoses

United States
University of Massachusetts, Worcester
Guerbet

Recruiting

Dotarem vs Gadobutrol Contrast for Breast MRI

Breast Diseases

United States
Donna Roberts
National Institute of Standards and Technology

Recruiting

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Magnetic Resonance Imaging | Gadolinium Retention | Gadolinium | MultiHance | Dotarem

United States
National Institutes of Health Clinical Center (CC)

Recruiting

Magnetic Resonance Imaging (MRI) Ofl Volunteers

Healthy Volunteers | Patients

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Hepatocellular Carcinoma | Liver and Intrahepatic Bile Duct Disorder | Metastatic Malignant Neoplasm in the Liver | Primary Malignant Liver Neoplasm

United States
Massachusetts General Hospital

Withdrawn

PET/MRI in Endometrial Cancer

Endometrial Mixed Cell Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Cytoreductive Surgery | High Grade Serous Carcinoma | Grade 3 Endometrial Endometrioid Adenocarcinoma

United States
NYU Langone Health

Active, not recruiting

Diffusion MRI for Head and Neck Cancer

Head Cancer Neck

United States
Uniformed Services University of the Health Sciences
Walter Reed National Military Medical Center

Terminated

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military

Traumatic Brain Injury

United States
NYU Langone Health

Completed

Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD

Alzheimer Disease

United States
Bayer

Completed

Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

Central Nervous System Pathology

United States, Japan, Germany, Bulgaria
NYU Langone Health

Active, not recruiting

Research on Infarction With Open Arteries Using OCT and CMR (RIO)

Myocardial Infarction

United States
University of Utah

Completed

Novel Imaging Markers in SPMS

Multiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple Sclerosis

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Terminated

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Metastatic Malignant Neoplasm in the Brain | Primary Brain Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Malignant Solid Neoplasm

United States
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Active, not recruiting

Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy (ACRIN6690)

Liver Cancer

United States
Slagelse Hospital
Herlev Hospital

Enrolling by invitation

CMR in T2DM: The NSR Cohort

Diabetes Mellitus, Type 2 | Diabetic Cardiomyopathies | Coronary Microvascular Dysfunction | Cardiovascular Magnetic Resonance Imaging | Myocardium; Fibrosis

Denmark
Elisa Konofagou
National Institute on Aging (NIA)

Active, not recruiting

Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound

Alzheimer Disease

United States
Bayer

Completed

A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function

Contrast Enhancement in Magnetic Resonance Imaging

United States
Navitas Life Sciences GmbH
GE Healthcare; Bayer; Guerbet

Completed

Long-Term Retention of Gadolinium in Bone

Focus: Long-term Retention of Gadolinium-based Contrast Agent

Spain, Korea, Republic of, United States, Germany, Japan, Turkey
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Childhood Brain Neoplasm | Recurrent Childhood Brain Neoplasm

United States
Guerbet

Completed

Cardiac Safety Evaluation of P03277

Healthy Volunteers

Belgium
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Malignant Glioma | Metastatic Malignant Neoplasm in the Brain | Central Nervous System Lymphoma

United States
Oxford University Hospitals NHS Trust
National Institute for Health Research, United Kingdom

Terminated

Scar Location and Acute Haemodynamic Response to MultiPoint Pacing Study in Patients With Ischemic Cardiomyopathy

Heart Failure | Ischemic Cardiomyopathy

United Kingdom
Imperial College London
National Institute for Health Research, United Kingdom; Imperial College Healthcare...

Withdrawn

MRI Assessment of Myocardial Fibrosis Associated With Monocyte Phenotype in End Stage Renal Failure (CM3)

Myocardial Fibrosis | Heart Failure | End Stage Renal Failure on Dialysis | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe)

United Kingdom
Bayer

Completed

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose (LEADER 75)

Magnetic Resonance Imaging

United States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
Massachusetts General Hospital

Withdrawn

A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

Contrast Media Allergy

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

QSM and Regional DCE MRI Permeability Using GOCART Technique

Intracranial Neoplasm

United States
Cedars-Sinai Medical Center

Completed

Identification of Adverse Plaque Characteristics by Coronary MR Angiography

Coronary Artery Disease

United States
Bayer

Completed

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

Magnetic Resonance Imaging

United States, Canada, Germany
University Hospital, Grenoble
Guerbet

Terminated

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease (PROSPER)

Meniere's Disease

France
National Cancer Institute (NCI)

Completed

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

Prostate Cancer

United States
University Hospital, Montpellier

Completed

Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas (SPECIFY)

Low-grade Glioma

France
Stanford University
General Electric

Completed

Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury

ISCHEMIC CARDIOMYOPATHY

United States
Massachusetts General Hospital

Withdrawn

Use of Gadolinium in CT Pulmonary Angiography

Pulmonary Embolism

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

Healthy

United States

Search clinical trials for: Gadolinium Contrast

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations